ImmunityBio,
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunityBio, and other ETFs, options, and stocks.About IBRX
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
CEORichard Adcock
CEORichard Adcock
Employees680
Employees680
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees680
Employees680
IBRX Key Statistics
Market cap2.06B
Market cap2.06B
Price-Earnings ratio-4.95
Price-Earnings ratio-4.95
Dividend yield—
Dividend yield—
Average volume16.63M
Average volume16.63M
High today$2.14
High today$2.14
Low today$2.00
Low today$2.00
Open price$2.09
Open price$2.09
Volume41.73M
Volume41.73M
52 Week high$4.27
52 Week high$4.27
52 Week low$1.83
52 Week low$1.83
Stock Snapshot
ImmunityBio,(IBRX) stock is priced at $2.10, giving the company a market capitalization of 2.06B. It carries a P/E multiple of -4.95.
As of 2025-12-21, ImmunityBio,(IBRX) stock has fluctuated between $2.00 and $2.14. The current price stands at $2.10, placing the stock +5.0% above today's low and -1.9% off the high.
ImmunityBio,(IBRX) shares are trading with a volume of 41.73M, against a daily average of 16.63M.
In the last year, ImmunityBio,(IBRX) shares hit a 52-week high of $4.27 and a 52-week low of $1.83.
In the last year, ImmunityBio,(IBRX) shares hit a 52-week high of $4.27 and a 52-week low of $1.83.
People also own
Based on the portfolios of people who own IBRX. This list is generated using Robinhood data, and it’s not a recommendation.